Raymond James Financial
OGN icon

Raymond James Financial’s Organon & Co OGN Stock Holding History

Raymond James Financial’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,400
Closed -$212K – 5410
2025
Q4 		$212K Buy
+35,400
New +$280K ﹤0.01% 4759

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Raymond James Financial's OGN Position: Q1 2026 in Review

Raymond James Financial increased its Organon & Co (OGN) stake by 27% in Q1 2026, buying an estimated $526K and bringing the position to 327,935 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3375.

Raymond James Financial first reported a position in OGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.74M in Q1 2025. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Raymond James Financial held 327,935 shares of Organon & Co worth $1.96M as of Q1 2026.
  • Raymond James Financial bought 69,903 Organon & Co shares in Q1 2026, an estimated $526K.
  • Organon & Co made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3375 holding.
  • Raymond James Financial first reported a position in Organon & Co in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Organon & Co position peaked at $4.74M in Q1 2025.
  • 606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.